Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Medulloblastoma Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT00360854
What this trial is testing

Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Children's Cancer and Leukaemia Group 48
Early research (Phase 1)WithdrawnNCT00458744
What this trial is testing

Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaLymphoma+1 more
Children's Oncology Group
Early research (Phase 1)Study completedNCT00784914
What this trial is testing

A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsMetastatic Cancer
City of Hope Medical Center 12
Early research (Phase 1)Ended earlyNCT00253721
What this trial is testing

Melphalan With BBBD in Treating Patients With Brain Malignancies

Who this might be right for
Brain and Central Nervous System TumorsLymphomaMetastatic Cancer
OHSU Knight Cancer Institute 21
Not applicableUnknownNCT00231712
What this trial is testing

Immuno 1: Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Stem Cell Transplant

Who this might be right for
LeukemiaMedulloblastoma
Julius-Maximilians University 50
Early research (Phase 1)Study completedNCT00003022
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+4 more
Memorial Sloan Kettering Cancer Center
Very early researchStudy completedNCT01737671
What this trial is testing

Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study

Who this might be right for
Brain TumorMalignant Neoplasm of Fourth Ventricle of Brain
M.D. Anderson Cancer Center 7
Early research (Phase 1)Study completedNCT00003765
What this trial is testing

O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT00867568
What this trial is testing

TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma

Who this might be right for
NeuroblastomaMedulloblastomaRelapse
Giselle Sholler 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06485908
What this trial is testing

Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and Ependymoma

Who this might be right for
MedulloblastomaEpendymoma
Assistance Publique Hopitaux De Marseille 40
Early research (Phase 1)Looking for participantsNCT05298995
What this trial is testing

GD2-CAR T Cells for Pediatric Brain Tumours

Who this might be right for
Brain Tumor, PediatricMedulloblastoma, ChildhoodEmbryonal Tumor+4 more
Bambino Gesù Hospital and Research Institute 54
Early research (Phase 1)Study completedNCT01682746
What this trial is testing

Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors

Who this might be right for
Brain Tumor, Recurrent
Harry T Whelan, MD 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT05128903
What this trial is testing

Quantitative Assessment of Radiation-induced Neuroinflammation - A Proof of Principle Study

Who this might be right for
Brain TumorMedulloblastoma
St. Jude Children's Research Hospital 22
Large-scale testing (Phase 3)Study completedNCT01351870
What this trial is testing

Hyperfractionated Versus Conventionally Fractionated Radiotherapy in Standard Risk Medulloblastoma (PNET4)

Who this might be right for
Medulloblastoma
Institut Curie 52
Testing effectiveness (Phase 2)Study completedNCT02017964
What this trial is testing

Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma

Who this might be right for
Desmoplastic/Nodular MedulloblastomaMedulloblastomaMedulloblastoma With Extensive Nodularity+1 more
Children's Oncology Group 26
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Not applicableEnded earlyNCT00897286
What this trial is testing

Study of Stored Tumor Samples in Young Patients With Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
St. Jude Children's Research Hospital 139
Testing effectiveness (Phase 2)Study completedNCT00003846
What this trial is testing

Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastoma
Children's Oncology Group 25
Testing effectiveness (Phase 2)UnknownNCT00180791
What this trial is testing

High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood

Who this might be right for
MedulloblastomaBrain TumorsNeuroectodermal Tumors, Primitive
Gustave Roussy, Cancer Campus, Grand Paris 71
Early research (Phase 1)Study completedNCT00880308
What this trial is testing

Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor CancersMedulloblastomaBasal Cell Carcinoma
Novartis Pharmaceuticals 103
Next Page